Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Podda

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
Alimentary Pharmacology & Therapeutics|September 13, 2001
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patientsP M Battezzati, M Zuin, A Crosignani, et al.
Arzneimittel-Forschung|October 29, 2000
Gastrointestinal tolerability of ibuprofen administered in two pharmaceutical formulationsM Zuin, M Podda, C Selmi, et al.
Italian Journal of Gastroenterology and Hepatology|March 26, 1999
Exacerbation of chronic hepatitis D during interferon alpha administrationA Crosignani, P Invernizzi, R Ferrari, et al.
BMJ (Clinical Research Ed.)|June 1, 1991
Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary reportM Borzio, S Bruno, M Roncalli, et al.
Tissue Antigens|February 9, 2011
Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patientsA Tanaka, H Ohira, K Kikuchi, et al.
Hepatology (Baltimore, Md.)|February 1, 1991
Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response studyA Crosignani, P M Battezzati, K D Setchell, et al.
Journal of Hepatology|March 1, 1993
Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBCP M Battezzati, M Podda, F B Bianchi, et al.
Cancer Treatment Reviews|August 8, 2008
Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgeryA Paradisi, D Abeni, A Rusciani, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosisP Invernizzi, A Crosignani, P M Battezzati, et al.
Hepato-Gastroenterology|March 28, 2001
Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resectionA Chiappa, A P Zbar, M Podda, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
Alimentary Pharmacology & Therapeutics|September 13, 2001
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patientsP M Battezzati, M Zuin, A Crosignani, et al.
Arzneimittel-Forschung|October 29, 2000
Gastrointestinal tolerability of ibuprofen administered in two pharmaceutical formulationsM Zuin, M Podda, C Selmi, et al.
Italian Journal of Gastroenterology and Hepatology|March 26, 1999
Exacerbation of chronic hepatitis D during interferon alpha administrationA Crosignani, P Invernizzi, R Ferrari, et al.
BMJ (Clinical Research Ed.)|June 1, 1991
Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary reportM Borzio, S Bruno, M Roncalli, et al.
Tissue Antigens|February 9, 2011
Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patientsA Tanaka, H Ohira, K Kikuchi, et al.
Hepatology (Baltimore, Md.)|February 1, 1991
Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response studyA Crosignani, P M Battezzati, K D Setchell, et al.
Journal of Hepatology|March 1, 1993
Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBCP M Battezzati, M Podda, F B Bianchi, et al.
Cancer Treatment Reviews|August 8, 2008
Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgeryA Paradisi, D Abeni, A Rusciani, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosisP Invernizzi, A Crosignani, P M Battezzati, et al.
Hepato-Gastroenterology|March 28, 2001
Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resectionA Chiappa, A P Zbar, M Podda, et al.
Pageof 19